🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg an...
Status
Completed
Location
UF Health Shands Children's Hospital
Start Date
2018-06-15
Trial ID
NCT03513328
Treatments Being Tested
This study involves the use of a drug called Thymoglobulin, which is approv...
Status
Completed
Location
University of Alabama-Birmingham Hospital
Start Date
2004-03
Trial ID
NCT00088543
The purpose of the study is to evaluate the feasibility and safety of trans...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2000-08
Trial ID
NCT00185692
The purpose of this study is to see if kidney function can be improved duri...
Status
Completed
Location
Ilene Blechman-Krom
Start Date
2000-04
Trial ID
NCT00007787
Treatments Being Tested
This is a phase II multi-institutional therapeutic study of NK-cell based n...
Status
Completed
Location
Emory University
Start Date
2011-09
Trial ID
NCT01370213
This study has been set up within the framework of the INNODIA network. INN...
Status
Completed
Location
Medical University of Graz
Start Date
2020-11-24
Trial ID
NCT04509791
Treatments Being Tested
The goal of this clinical trial is to learn if siplizumab can prevent rejec...
Status
Recruiting
Location
UC Davis Medical Center
Start Date
2026-06-29
Trial ID
NCT07508787
Treatments Being Tested
Patients less than or equal to 21 years old with high-risk hematologic mali...
Status
Active Not Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2019-01-31
Trial ID
NCT03849651
This phase II trial investigates side effects and how well donor stem cell ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-08-19
Trial ID
NCT04530487
This is a randomized, controlled, single center study to evaluate the effic...
Status
Enrolling By Invitation
Location
Kaiser Permanente Los Angeles Medical Center
Start Date
2018-09-13
Trial ID
NCT03292861
Treatments Being Tested